Company intelligence
Marblehead & Company
Strategic advisory, visibility, and capital for those building the future of healthcare.
About Marblehead & Company
Healthcare has three kinds of builders. 1. Health system executives trying to figure out which AI bets are real and which are vapor. 2. Venture investors trying to get portfolio companies through a health system front door without a two-year sales cycle. 3. Founders who've built something genuinely valuable and can't figure out why no one is buying it. All three are stuck in the same conversation. They just can't find each other. Marblehead & Co. is a boutique advisory firm built to solve that problem. We work at the intersection of healthcare capital, clinical operations, and commercial strategy — the exact space where most deals get stuck and most innovation programs stall. Our work spans three practice areas: For health systems: venture portfolio strategy, AI adoption frameworks, and innovation program design. We help executive teams move from "we have a committee" to "we have a strategy" — and build programs that generate real financial and strategic returns, not just press releases. For investors: portfolio company support, health system market access, and deal diligence grounded in two decades of pattern recognition across 150+ healthcare companies, 10 venture funds, and $40M deployed. For founders: enterprise sales strategy, health system navigation, and the kind of honest feedback that only comes from someone who's been on the other side of the table when you pitched. The firm was founded by Doug Hayes, who brings 20 years at the intersection of healthcare, technology, and capital. Partner at Blueprint Health. Founder of Junto Health, a 60+ health system advisory network. Executive Director of venture and innovation at a major health system, where he deployed $40M across 10 funds and built a top-decile portfolio. The vision is yours. The navigation is ours. marblehead.ai | doug@marblehead.ai | 215-620-2032
Verified activity
Signals from Marblehead & Company
2 published signals